Michael Andriole
Vorstandsvorsitzender bei CHIMERIX, INC.
Vermögen: 398 296 $ am 30.04.2024
Aktive Positionen von Michael Andriole
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CHIMERIX, INC. | Direktor/Vorstandsmitglied | 01.08.2023 | - |
Vorstandsvorsitzender | 01.08.2023 | - | |
Präsident | 01.08.2023 | - | |
Finanzdirektor/CFO | 31.05.2019 | 01.08.2023 | |
Corporate Officer/Principal | 08.04.2019 | 31.05.2019 |
Karriereverlauf von Michael Andriole
Ehemalige bekannte Positionen von Michael Andriole
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ENDOCYTE, INC. | Finanzdirektor/CFO | 21.02.2017 | 01.12.2018 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.08.2006 | 01.02.2017 |
Ausbildung von Michael Andriole
Williams College of Business | Undergraduate Degree |
Kelley School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
CHIMERIX, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Börse
- Insiders
- Michael Andriole
- Erfahrung